A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : aPL / antiphospholipid antibodies

[Related PubMed/MEDLINE]
Total Number of Papers: 1307
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   aPL  (>> Co-occurring Abbreviation)
Long Form:   antiphospholipid antibodies
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A novel de novo MTOR gain-of-function variant in a patient with Smith-Kingsmore syndrome and Antiphospholipid syndrome. APS, GOF, OXPHOS, SKS, WES
2019 Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements. aCL, APS, LA, SN-APS
2019 Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome. beta2GPI, HMGB1, SLE, sRAGE
2019 Antiphospholipid syndrome and pregnancy. APS
2019 Are serum autoantibodies associated with brain changes in systemic lupus erythematosus? MRI data from the Leiden NP-SLE cohort. aCL, LAC, SLE, WMHs
2019 Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation. APS, IFN, PAPS, PBMCs, SLE/APS, SNP, TLR
2019 Clinical Phenotype of a First Unprovoked Acute Pulmonary Embolism Associated with Antiphospholipid Antibody Syndrome. CI, OR, PE
2019 Clinical profiles and risk assessment in patients with antiphospholipid antibodies. APS
2019 Comparison of celiac disease markers in women with early recurrent pregnancy loss and normal controls. CD, DGP, ELISA, EMA, RPL, tTG
10  2019 Complement in the Pathophysiology of the Antiphospholipid Syndrome. APS
11  2019 Cryptic conspirators: a conversation about thrombocytopenia and antiphospholipid syndrome. APS
12  2019 Detection of Anti-Cardiolipin and Anti-beta2glycoprotein I Antibodies Differs between Platforms without Influence on Association with Clinical Symptoms. abeta2GPI, aCL, APS, Arg, Gly, Ig, LAC, MoAb, ORs
13  2019 Diagnosing and treating antiphospholipid syndrome: a consensus paper. APS, LAC, VKA
14  2019 Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study. aGAPSS, APS, Ob-APS, PM
15  2019 Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction. HAEC, HCQ, TF, TGT
16  2019 IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers. LAC, OR
17  2019 Insights into the diagnosis and pathogenesis of the antiphospholipid syndrome. APS
18  2019 Management of pregnant women with antiphospholipid antibodies. APS
19  2019 New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches. aCL, APS, LA, MHC
20  2019 Nonthrombotic proliferative vasculopathy associated with antiphospholipid antibodies: A case report and literature review. NTPV
21  2019 Platelet Activation by Antiphospholipid Antibodies Depends on Epitope Specificity and is Prevented by mTOR Inhibitors. APS, beta2GPI, IgG, mTOR
22  2019 Preeclampsia in pregnancies complicated by systemic lupus erythematosus (SLE) nephritis: prophylactic treatment with multidisciplinary approach are important keys to prevent adverse obstetric outcomes. eGFR, IUGR, SLE
23  2019 Prevalence and associations of anti-phosphatidylserine/prothrombin antibodies with clinical phenotypes in patients with primary antiphospholipid syndrome: aPS/PT antibodies in primary antiphospholipid syndrome. APS, LA
24  2019 Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study. APS, LA, VKA
25  2019 Role of NOD2 in antiphospholipid antibody-induced and bacterial MDP amplification of trophoblast inflammation. MDP
26  2019 Role of TLR‑4 in anti‑beta2‑glycoprotein I‑induced activation of peritoneal macrophages and vascular endothelial cells in mice. APS, beta2GPI, IL, LPS, MAPK, VECs
27  2019 The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis. abeta2GPI, aCL
28  2019 The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases. EUROAPS, FGR, LDA, LMWH, OAPS, PE
29  2019 The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository. anti-beta2 GPI, SLE
30  2019 Treatment of refractory poor aPL-related obstetric outcomes with TNF-alpha blockers: Maternal-fetal outcomes in a series of 18 cases. HCQ, LMWH, OAPS
31  2019 Which place of antiphosphatidylethanolamine antibodies research in seronegative antiphospholipid syndrome suspicion? aPE, APS, ELISA, SN-APS
32  2018 A Monocentric Cohort of Obstetric Seronegative Anti-Phospholipid Syndrome. abeta2GPI, aCL, APS, OAPS, SN-APS, TLC
33  2018 Acquired von Willebrand Syndrome due to Aortic Valve Stenosis in a Case with Antiphospholipid Antibody. APTT, AVWS, vWF
34  2018 Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies. anti-beta2GP, anti-dsDNA, CYC, SLE, SLEDAI
35  2018 Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases. abeta2GPI, aCL, aD1, aD4-5, aPG, APS, AUC, beta2GPI, HS, LIA, SARD
36  2018 Anti-phospholipid syndrome in seven leprosy patients with thrombotic events on corticosteroid and/or thalidomide regimen: insights on genetic and laboratory profiles. MB, ss2GPI, TBE
37  2018 Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia. APS, IUGR
38  2018 Antiphospholipid Antibodies and Heart Valve Disease in Systemic Lupus Erythematosus. OR, SLE
39  2018 Antiphospholipid antibodies and renal transplant: A systematic review and meta-analysis. OR
40  2018 Antiphospholipid antibodies in women with severe preeclampsia and placental insufficiency: a case-control study. abeta2GPI, aCL, AORs, APS, BMI, IgG, IgM, LA, PREPI
41  2018 Antiphospholipid antibodies induce thrombosis by PP2A activation via apoER2-Dab2-SHC1 complex formation in endothelium. ApoER2, APS, Dab2, eNOS, PP2A, Shc1
42  2018 Antiphospholipid Antibodies Inhibit Trophoblast Toll-Like Receptor and Inflammasome Negative Regulators. anti-beta2 GPI, ELISA, GAS6, IL-8, MerTK, qRT-PCR, TLR4
43  2018 Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I. ab2GPI, APS, DI
44  2018 Antiphospholipid syndrome - an update. APS, b2-GP I, CAPS, LA
45  2018 Antiphospholipid syndrome and IgA anti-beta2-glycoprotein I antibodies: when Cinderella becomes a princess. APS, IgA-aB2GPI
46  2018 Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy. APS
47  2018 Antiphospholipid syndrome, "the best prophet of the future". APS
48  2018 Are the cutaneous manifestations in patients with primary antiphospholipid syndrome a marker for predicting lung manifestations? PAPS
49  2018 Arterial stenosis in antiphospholipid syndrome: Update on the unrevealed mechanisms of an endothelial disease. APS
50  2018 beta2-Glycoprotein I-Reactive T Cells in Autoimmune Disease. APS, beta2GPI, MHC, SLE, Th
51  2018 Brain magnetic resonance imaging, cerebrospinal fluid, and autoantibody profile in 118 patients with neuropsychiatric lupus. aCL, ACR, NPSLE
52  2018 Catastrophic antiphospholipid syndrome (Ronald Asherson syndrome) and obstetric pathology. APS, CAPS
53  2018 Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report. CAPS, NYHA
54  2018 Clinical feature and anti-phospholipid antibody profiles of pregnancy failure in young women with antiphospholipid antibody syndrome treated with conventional therapy. APS, CL, LA, PS/PT
55  2018 Cofactor-Independent Antiphospholipid Antibodies: Implications for Pathogenesis, Diagnosis, and Treatment of Antiphospholipid Syndrome. APS
56  2018 Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus. APO, OR, SES, SLE
57  2018 Development of a thrombin generation test in cultured endothelial cells: Evaluation of the prothrombotic effects of antiphospholipid antibodies. APS, CAT, TG
58  2018 Effect and mechanism of the abeta2‑GP I/rhbeta2‑GP I complex on JEG‑3 cell proliferation, migration and invasion. APS, NF, rh
59  2018 Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodies. aCL, SLE
60  2018 Extra-criteria manifestations of antiphospholipid syndrome: Risk assessment and management. aGAPSS, APS, PAPS
61  2018 Extracellular Vesicles in the Antiphospholipid Syndrome. APS, EVs, microRNA, MPs
62  2018 Factors associated with increased white matter hyperintense lesion (WMHI) load in patients with systemic lupus erythematosus (SLE). DWMHI, LN, MRI, NPSLE, SLE, WMHI
63  2018 First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-beta2 -Glycoprotein I Domain I and Anti-Phosphatidylserine/Prothrombin Complex Antibodies Tests. anti-beta2 GPI, aPL-S, APS
64  2018 Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome. APS, DE, DV, GO, PM, VT
65  2018 Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease. HCQ, RCT
66  2018 Hypercoagulability and Migraine. MA, MTHFR, OCP, PFO, tPA, vWF
67  2018 Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-beta2glycoprotein I antibody detection assays. abeta2GPI, aCL, APS, LAC, OR
68  2018 Identifying Additional Risk Factors for Thrombosis and Pregnancy Morbidities Among Antiphospholipid Antibodies Carriers. APS, CI, LA, OR
69  2018 IgA anti-beta2 glycoprotein I antibodies: Experience from a large center. APS, IgA abeta2GPI
70  2018 Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual. aCL, anti-beta2 GPI, APS, CI, Ig, LA, OR, SLE
71  2018 Immunoglobulins from sera of antiphospholipid syndrome patients are internalized in the HTR-8/SVneo cell line and cytotrophoblast in culture. APS, CT
72  2018 In vitro fertilization outcomes in women with antiphospholipid antibodies circulation. ART, LMWH
73  2018 Laboratory Diagnostics of Antiphospholipid Syndrome. APS
74  2018 Length of exposure to antiphospholipid antibodies, rather than age, is a risk factor for thrombosis: a retrospective single-centre observational study. OR
75  2018 Low molecular weight heparin and aspirin exacerbate human endometrial endothelial cell responses to antiphospholipid antibodies. HEECs, LMWH
76  2018 Lupus anticoagulant testing using two parallel methods detects additional cases and predicts persistent positivity. aB2GPI, aCL, LA
77  2018 Management of Thrombotic Antiphospholipid Syndrome. APS
78  2018 Mechanisms of Cellular Activation in the Antiphospholipid Syndrome. ANXA2, beta2GPI, LRP8, TLR4
79  2018 Mechanisms of Endothelial Dysfunction in Antiphospholipid Syndrome: Association With Clinical Manifestations. APS
80  2018 Microthrombotic renal involvement in an SLE patient with concomitant catastrophic antiphospholipid syndrome: the beneficial effect of rituximab treatment. SLE
81  2018 Multifocal avascular osteonecrosis despite appropriate anticoagulation therapy in a patient with systemic lupus erythematosus and antiphospholipid syndrome. AON, SLE
82  2018 Mycophenolate mofetil therapy for two cases of antiphospholipid antibody-associated chorea. MMF
83  2018 New Insights in the Pathophysiology of Antiphospholipid Syndrome. ApoER2, APS, NO
84  2018 Obstetric Anti-phospholipid Syndrome: State of the Art. Ob-APS
85  2018 Obstetric APS and thrombosis; modelling future risks. Ob-APS, RPL
86  2018 Oxidative post-translational modification of betaeta 2-glycoprotein I in the pathophysiology of the anti-phospholipid syndrome. APS, beta2GPI
87  2018 Pathogenesis of antiphospholipid syndrome: recent insights and emerging concepts. APS, NETs
88  2018 PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome. APS, beta2GPI, DI, PEG-DI
89  2018 Potential therapeutics for antiphospholipid antibody associated thrombocytopenia: a systematic review and meta-analysis. APAT, CIs, RRs
90  2018 Preconception antiphospholipid antibodies and risk of subsequent early pregnancy loss. a-beta2-I, aCL, CI, EPL
91  2018 Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis. aCL, anti-beta2GPI, LA, SSc, VT
92  2018 Prevalence and Thrombotic Risk Assessment of Anti-beta2 Glycoprotein I Domain I Antibodies: A Systematic Review. ACR, anti-beta2GPI-DI, APS, ARHP, CI, EULAR, OR, SLE
93  2018 Prevalence of Antiphospholipid Antibody Positivity and Association of Pretransplant Lupus Anticoagulant Positivity With Early Allograft Dysfunction in Liver Transplantation. aCL, anti-beta2GPI, EAD, IPTW, LA, LDLT
94  2018 Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018? APS, ATIR, CVD
95  2018 Prognostic Value of Serum Antiphospholipid Antibodies in Patients with ST-Segment Elevation Myocardial Infarction. AMI, aPI, APS
96  2018 Pulmonary thromboendarterectomy is a curative resolution for chronic thromboembolic pulmonary hypertension associated with antiphospholipid syndrome: a retrospective cohort study. APS, CTEPH, PTE
97  2018 Renal involvement in antiphospholipid syndrome. APS, SLE, TMA
98  2018 Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome. aCL, APS, CR, eGFR, LA, LN
99  2018 Revisiting the Phadia/EliA cut-off values for anticardiolipin and anti-beta2-glycoprotein I antibodies: a systematic evaluation according to the guidelines. abeta2GPI, aCL, CI, CLSI, ISTH
100  2018 Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant). APS